Execs from Medisafe, Phreesia and Heartbeat share examples of POC programs that drove better short- and long-term adherence rates than seen before.

This year, the company launched the industry’s first end-to-end, holistic patient journey solution for medication management. The solution supports patients throughout the entirety of their medication journeys: Beginning at initiation with onboarding and first prescription fill guidance, while managing the complexities of complicated regimens, and now simplifying the med refill process by offering direct delivery…

In the continual evolution of technology, the healthcare industry still finds itself in the early stages of incorporating Artificial Intelligence(AI) into patient engagement. Initial deployment of ML focused on the priorities of providers, payers and supply chain. Patients certainly benefit when ML is incorporated in their care.

Medisafe and its partner’s joint program enrolled “thousands” of cardiometabolic patients and posted adherence increases greater those of the Medisafe app alone.

Digital therapeutic stakeholders came together at this week’s DTx East conference to discuss the state of digital health investment, developing successful business models, the need for robust data and more.

A panel discussion at the DTx East conference in Boston discussed whether partnerships between digital health and drugmakers were “a match made in heaven.”

Digital therapeutics clinical trials enable collection and analysis of data in real time, but considerations like standardization of analysis, trial endpoints and placebo controls are critical, experts at the DTx East conference in Boston said.

Medication non-adherence has major implications for the U.S. healthcare system, often causing otherwise effective therapies to fail. Non-adherence accounts for up to half of treatment failures, about 125,000 deaths, and nearly $300 billion in added healthcare costs each year.

Medisafe, a digital medication adherence app, is joining forces with Amerisource Bergen’s Lash Group in order to integrate the former’s management app into the latter’s hub services. The partnership seeks to help patients manage their medications and identify patients who need extra support.

Through their alliance, Medisafe will deliver real-time interventions to help patients stay adherent and will alert Lash Group’s clinicians when patients are considered “at-risk.”